Moderna MRNA Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 22.1%-32.0pp | 55.3%+0.6pp | 48.3%-19.2pp | 52.5%+19.5pp | 54.1%+31.7pp | |
| Operating margin | -153.3%-36.0pp | -158.1%-36.2pp | -155.2%-102pp | -106.3%-14.4pp | -117.4%-17.5pp | |
| Net margin | -143.6%-37.9pp | -145.2%-35.1pp | -139.6%-91.6pp | -94.3%+26.2pp | -105.7%+14.4pp | |
| EBITDA margin | -142.8%-31.5pp | -147.1%-31.0pp | -145.8%-99.2pp | -99.6%-18.1pp | -111.3%-22.7pp | |
| Returns | ||||||
| Return on equity | -36.6%-7.2pp | -28.9%-0.1pp | -29.3%-10.1pp | -27.5%+15.0pp | -29.3%+9.7pp | |
| Return on assets | -26.4%-3.6pp | -21.3%+0.6pp | -22.3%-8.5pp | -21%+11.4pp | -22.8%+7.5pp | |
| Return on invested capital | -42.5%-7.4pp | -35.9%+0.1pp | -33.6%-10.9pp | -33.8%+3.4pp | -35.2%+0.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.2×0.0× | 0.1×-0.1× | 0.2×-0.1× | 0.2×0.0× | 0.2×0.0× | |
| Inventory turnover | 13.8×+3.4× | 6.6×-2.6× | 12.8×+0.8× | 10.2×+2.5× | 10.5×+2.6× | |
| Liquidity | ||||||
| Current ratio | 2.4×-1.8× | 3.3×-0.4× | 3.9×-0.5× | 3.9×-0.2× | 4.2×+0.2× | |
| Quick ratio | 2.4×-1.8× | 3.2×-0.4× | 3.9×-0.5× | 3.8×-0.2× | 4.1×+0.2× | |
| Cash ratio | 0.8×-0.2× | 1.3×+0.4× | 0.7×-0.1× | 0.8×-0.2× | 1×+0.1× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×+0.1× | 0.2×+0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×+0.1× | 0.1×+0.1× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Per Share | ||||||
| Book value per share | $18.75-28.1% | $22.24-21.7% | $23.92-20.0% | $24.22-20.6% | $26.08-22.3% | |
| Valuation | ||||||
| Market capitalization | $20.15B+83.8% | $11.52B-28.0% | $10.05B-60.9% | $10.36B-77.2% | $10.96B-73.1% | |
| Enterprise value | $19.57B+93.6% | $10.26B-30.9% | $9.68B-61.9% | $9.85B-77.8% | $10.11B-74.7% | |
| Price / sales | 9.1×+5.6× | 5.9×+1.0× | 4.5×-0.6× | 3.4×-5.6× | 3.5×-4.5× | |
| Price / book | 2.7×+1.6× | 1.3×-0.1× | 1.1×-1.1× | 1.1×-2.8× | 1.1×-2.1× | |
| EV / sales | 8.8×+5.6× | 5.3×+0.7× | 4.3×-0.7× | 3.2×-5.6× | 3.2×-4.6× | |
| Earnings yield | -15.9%+14.8pp | -24.5%-2.2pp | -31%-21.5pp | -28%-14.6pp | -30.6%-15.5pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Moderna's profit margins?
- Moderna (MRNA) runs a 22.1% gross margin and a -153.3% operating margin, with a -143.6% net margin.
- Where do Moderna's ratios come from?
- Every ratio is computed from Moderna's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
